Amyotrophic Lateral Sclerosis: all 1,000 studies

Page 8 of 10. Open to participants first (284), then studies with results posted, then the rest; newest registration first within each.

• A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALSCompletedNCT03324399Not applicable
• Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral SclerosisCompletedNCT03321487Not applicable
• Intraspinal Transplantation of Autologous ADRC in ALS PatientsStatus unknownNCT03296501Phase 1
• Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral SclerosisCompletedNCT03293069Phase 2/3
• Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's AtaxiaStatus unknownNCT03285204
• Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT03272802Phase 2/3
• A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT03272503Phase 2
• Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female ParticipantsCompletedNCT03237741Phase 1
• Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALSStatus unknownNCT03214146Phase 1
• Dual Treatment With Lithium and Valproate in ALS.CompletedNCT03204500Phase 2
• Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALSCompletedNCT03202017Not applicable
• ALS Study Determining Various Biomarkers and Strength Comparison After ExerciseCompletedNCT03201991Not applicable
• A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.TerminatedNCT03196375Phase 2
• Open-label Clinical Trial of Lacosamide in ALSCompletedNCT03186040Phase 1/2
• EncoreAnywhere Use in Motor Neurone DiseaseCompletedNCT03154450Not applicable
• Brown Adipose Tissue in ALSCompletedNCT03150290Not applicable
• ALS Treatment Extension StudyStatus unknownNCT03136809Phase 1/2
• Effect of MD1003 in Amyotrophic Lateral SclerosisCompletedNCT03114215Phase 2
• Virtual Task in Amyotrophic Lateral SclerosisCompletedNCT03113630Not applicable
• Trial of Amivita in Amyotrophic Lateral SclerosisStatus unknownNCT03103815Not applicable
• NeuroCognitive Communicator: Safety StudyStatus unknownNCT03100110Not applicable
• An Online Mindfulness Intervention for People With ALS and Their CaregiversCompletedNCT03095989Not applicable
• Cognitive Consequences of an Activation of the Cortical Drive to Breath (VENTIPSY)CompletedNCT03095729
• Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALSTerminatedNCT03090932
• Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral SclerosisCompletedNCT03085706Not applicable
• A Programme for Amyotrophic Lateral Sclerosis Care in EuropeCompletedNCT03081338
• Interactions Between Neurostimulation and Physical ExerciseWithdrawnNCT03076632Not applicable
• Amyotrophic Lateral Sclerosis: a New ParadigmCompletedNCT03073239
• Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron DiseaseStatus unknownNCT03067857Phase 1/2
• CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALSStatus unknownNCT03049046Phase 1
• MIROCALS: Modifying Immune Response and OutComes in ALSCompletedNCT03039673Phase 2
• NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT03034317Not applicable
• A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03020797Not applicable
• Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03019419Phase 2
• ALS Testing Through Home-based Outcome MeasuresCompletedNCT03016897
• Nebulized RNS60 for the Treatment of Amyotrophic Lateral SclerosisWithdrawnNCT02988297Phase 2
• Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis PatientsCompletedNCT02987413Phase 1
• Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral SclerosisStatus unknownNCT02969759Early Phase 1
• Delineating Swallowing Impairment and Decline in ALSCompletedNCT02962050
• CNS10-NPC-GDNF for the Treatment of ALSCompletedNCT02943850Phase 1
• Diaphragmatic Pacer Placement: Anesthetic Management (DP)CompletedNCT02942953
• Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral SclerosisStatus unknownNCT02917681Phase 1/2
• Environmental Exposure and Neurological Diseases QuestionnaireCompletedNCT02916966
• Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral SclerosisCompletedNCT02893605
• Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT02881489Phase 1
• Therapeutic Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT02881476Phase 1
• Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating LymphocytesCompletedNCT02880033Not applicable
• Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral SclerosisStatus unknownNCT02874209Not applicable
• Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MNDCompletedNCT02870634Phase 1
• Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).CompletedNCT02868580Phase 2
• A Patient Centric Motor Neuron Disease Activities of Daily Living ScaleCompletedNCT02852278
• SSRIs vs. TCAs for Depression in ALS PatientsCompletedNCT02851914Early Phase 1
• Deep Phenotyping in Patients With ALSCompletedNCT02819765
• Genomic Translation for Amyotrophic Lateral Sclerosis CareCompletedNCT02795897
• Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic InflammationCompletedNCT02794857Phase 2
• Muscle Oxygenation in Effort in Neuromuscular DiseasesCompletedNCT02789059Not applicable
• A Study to Evaluate the Performance of a Diagnostic Test in ALSStatus unknownNCT02759913
• Nightime NIV Initiation in Amyotrophic Lateral Sclerosis in an Outpatient SettingCompletedNCT02759003Not applicable
• Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.CompletedNCT02750982Not applicable
• Evaluation of Usability and Human Factors in the Novus SystemStatus unknownNCT02738242Not applicable
• Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710162Early Phase 1
• Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710110Early Phase 1
• Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALSCompletedNCT02686268
• Muscular Biomarkers in Amyotrophic Lateral SclerosisCompletedNCT02670226Not applicable
• Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT02665663Not applicable
• A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral SclerosisCompletedNCT02655614Phase 1
• Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALSCompletedNCT02645461Not applicable
• Methodology Study of Novel Outcome Measures to Assess Progression of ALSCompletedNCT02611674
• Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02590276Not applicable
• Food Supplement for the Treatment of Patients With Amyotrophic Lateral SclerosisWithdrawnNCT02588807Phase 1
• Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02588677Phase 2/3
• In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02582385
• Answer ALS: Individualized Initiative for ALS DiscoveryCompletedNCT02574390
• Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)CompletedNCT02572479
• Imaging and BioFluid Biomarkers in Amyotrophic Lateral SclerosisCompletedNCT02559869
• Sport Therapy and Osteopathy Manipulative Treatment in ALSCompletedNCT02548663Not applicable
• "New Perspectives of Adaptation to NIV in ALS"CompletedNCT02537132Not applicable
• Genetics of Pediatric-Onset Motor Neuron and Neuromuscular DiseasesCompletedNCT02532244
• Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral SclerosisTerminatedNCT02528071
• Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02507713
• Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALSCompletedNCT02492516Phase 1
• Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral SclerosisCompletedNCT02487407Phase 2
• Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALSCompletedNCT02469675Not applicable
• Assessment of the Effects of Sheffield Support Snood in MND PatientsCompletedNCT02464852Not applicable
• A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALSStatus unknownNCT02463825Phase 2
• Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral SclerosisCompletedNCT02457715
• Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS PatientsStatus unknownNCT02424669Not applicable
• F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral SclerosisCompletedNCT02414230
• Microglial Activation Role In ALS (MARIA)WithdrawnNCT02405403Early Phase 1
• MRI Biomarkers in ALSCompletedNCT02405182
• Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral SclerosisCompletedNCT02383654Phase 1
• Accurate Test of Limb Isometric Strength (ATLIS) in ALSStatus unknownNCT02374606
• Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)CompletedNCT02365922
• Study of Predictive Factors of Progression of Motor Neurone DiseaseCompletedNCT02360891
• Phenotype, Genotype & Biomarkers in ALS and Related DisordersActive, not recruitingNCT02327845
• sCD163 in ALS PatientsCompletedNCT02325375
• European Home Mechanical Ventilation RegistryTerminatedNCT02315339
• A New Eye-based Communication Device for ALS PatientsCompletedNCT02313402Not applicable
• Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral SclerosisCompletedNCT02306590Not applicable
• Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02306109Not applicable

← Amyotrophic Lateral Sclerosis overview